About the journal
ARYA Atherosclerosis is an open-access journal published by Vesnu Publications in Iran, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,500,000 IRR. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Vesnu Publications
- ISSN
- 1735-3955 · 2251-6638
- Country
- Iran
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,500,000 IRR
- Articles in DOAJ
- 800
- Declared review time
- 18 weeks
- Declared peer-review model
- double_blind
- Official website
- http://arya.mui.ac.ir
Index listings
- DOAJ · 2018-05-11
- Indexing
- DOAJ
- APC
- 3,500,000 IRR
- Declared review time (DOAJ)
- 18 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
800
Most recent article
3 years ago
Average review time (journal-declared via DOAJ)
18weeks
Works in OpenAlex
35
Last recorded publication year
2021
h-index
6
i10-index
2
From OpenAlex open data (CC0).
Editorial & policy7
- Last DOAJ review date
- 2023-02-15
- Added to DOAJ
- 2018-05-11
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101487337
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiovascular Function and Risk Factors
- Cardiac Health and Mental Health
- Cardiovascular Function and Risk Factors
- Cardiac Health and Mental Health
- Adipokines, Inflammation, and Metabolic Diseases
- Heart Rate Variability and Autonomic Control
Show all subjects (50)
- Cardiac Arrhythmias and Treatments
- Chronic Disease Management Strategies
- Diet and metabolism studies
- Diet, Metabolism, and Disease
- Obesity and Health Practices
- Obesity, Physical Activity, Diet
- Coronary Interventions and Diagnostics
- Cardiac electrophysiology and arrhythmias
- Acute Myocardial Infarction Research
- Lipoproteins and Cardiovascular Health
- Obesity and Health Practices
- Obesity, Physical Activity, Diet
- Diet, Metabolism, and Disease
- Diet and metabolism studies
- Chronic Disease Management Strategies
- Cardiac Arrhythmias and Treatments
- Heart Rate Variability and Autonomic Control
- Adipokines, Inflammation, and Metabolic Diseases
- Lipoproteins and Cardiovascular Health
- Acute Myocardial Infarction Research
- Cardiac electrophysiology and arrhythmias
- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Liver Disease Diagnosis and Treatment
- Anesthesia and Pain Management
- Cardiac Valve Diseases and Treatments
- Blood Pressure and Hypertension Studies
- Atrial Fibrillation Management and Outcomes
- Smoking Behavior and Cessation
- Congenital Heart Disease Studies
- Atrial Fibrillation Management and Outcomes
- Blood Pressure and Hypertension Studies
- Cardiac Valve Diseases and Treatments
- Anesthesia and Pain Management
- Fatty Acid Research and Health
- Mental Health Treatment and Access
- Fatty Acid Research and Health
- Smoking Behavior and Cessation
- Cardiac Imaging and Diagnostics
- Liver Disease Diagnosis and Treatment
- Congenital Heart Disease Studies
- Mental Health Treatment and Access
Keywords (DOAJ)
- cardiology
- medicine
- atherosclerosis
- diseasae
- cardiovascular disease
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ